Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 13 | 2023 | 617 | 3.330 |
Why?
|
| Pneumonia, Viral | 5 | 2020 | 185 | 2.880 |
Why?
|
| Coronavirus Infections | 5 | 2020 | 194 | 2.830 |
Why?
|
| Alzheimer Disease | 11 | 2023 | 369 | 2.820 |
Why?
|
| Apathy | 10 | 2023 | 47 | 2.530 |
Why?
|
| Pandemics | 8 | 2023 | 596 | 2.110 |
Why?
|
| Depressive Disorder | 5 | 2020 | 369 | 1.440 |
Why?
|
| Transcranial Magnetic Stimulation | 3 | 2020 | 81 | 1.430 |
Why?
|
| Occupational Exposure | 2 | 2021 | 129 | 1.380 |
Why?
|
| Methylphenidate | 6 | 2023 | 94 | 1.370 |
Why?
|
| Anxiety | 2 | 2020 | 279 | 1.280 |
Why?
|
| Exercise Therapy | 2 | 2019 | 123 | 1.140 |
Why?
|
| Activities of Daily Living | 6 | 2023 | 205 | 1.070 |
Why?
|
| Cognition Disorders | 3 | 2012 | 240 | 0.960 |
Why?
|
| Caregivers | 4 | 2020 | 239 | 0.950 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 43 | 0.910 |
Why?
|
| Accidental Falls | 2 | 2017 | 98 | 0.890 |
Why?
|
| Videoconferencing | 2 | 2020 | 40 | 0.870 |
Why?
|
| Aged | 26 | 2023 | 10048 | 0.840 |
Why?
|
| Walking | 4 | 2020 | 110 | 0.830 |
Why?
|
| World War II | 1 | 2021 | 11 | 0.820 |
Why?
|
| Awards and Prizes | 1 | 2021 | 20 | 0.810 |
Why?
|
| Narration | 1 | 2021 | 31 | 0.800 |
Why?
|
| Cognition | 5 | 2018 | 351 | 0.770 |
Why?
|
| Social Isolation | 2 | 2021 | 29 | 0.770 |
Why?
|
| Air Pollutants, Occupational | 1 | 2020 | 18 | 0.760 |
Why?
|
| Fear | 2 | 2020 | 87 | 0.730 |
Why?
|
| Rural Health | 1 | 2020 | 102 | 0.720 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2012 | 150 | 0.710 |
Why?
|
| Research Subjects | 1 | 2020 | 57 | 0.700 |
Why?
|
| Double-Blind Method | 9 | 2023 | 744 | 0.670 |
Why?
|
| Music | 1 | 2018 | 6 | 0.670 |
Why?
|
| Executive Function | 2 | 2018 | 80 | 0.670 |
Why?
|
| Time Perception | 1 | 2018 | 30 | 0.660 |
Why?
|
| Auditory Perception | 1 | 2018 | 28 | 0.660 |
Why?
|
| Military Personnel | 1 | 2020 | 173 | 0.650 |
Why?
|
| Postural Balance | 2 | 2017 | 61 | 0.650 |
Why?
|
| Humans | 45 | 2023 | 54356 | 0.650 |
Why?
|
| Stress, Psychological | 1 | 2020 | 270 | 0.650 |
Why?
|
| Male | 31 | 2023 | 27319 | 0.650 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 89 | 0.640 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2018 | 31 | 0.640 |
Why?
|
| Telemedicine | 2 | 2020 | 457 | 0.600 |
Why?
|
| Sensation Disorders | 1 | 2017 | 14 | 0.590 |
Why?
|
| Biomedical Research | 1 | 2020 | 242 | 0.580 |
Why?
|
| User-Computer Interface | 2 | 2018 | 92 | 0.540 |
Why?
|
| Depression | 2 | 2020 | 596 | 0.520 |
Why?
|
| Independent Living | 4 | 2020 | 46 | 0.520 |
Why?
|
| Dementia | 3 | 2023 | 150 | 0.510 |
Why?
|
| Aged, 80 and over | 10 | 2021 | 3427 | 0.510 |
Why?
|
| Central Nervous System Stimulants | 4 | 2020 | 259 | 0.480 |
Why?
|
| Pilot Projects | 5 | 2023 | 802 | 0.430 |
Why?
|
| Loneliness | 3 | 2021 | 13 | 0.430 |
Why?
|
| Vaccines | 1 | 2023 | 65 | 0.410 |
Why?
|
| Video Games | 1 | 2011 | 13 | 0.400 |
Why?
|
| Female | 18 | 2023 | 28447 | 0.390 |
Why?
|
| Mianserin | 1 | 2010 | 8 | 0.380 |
Why?
|
| Hallucinations | 1 | 2010 | 18 | 0.370 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2010 | 32 | 0.370 |
Why?
|
| Middle Aged | 13 | 2022 | 13055 | 0.360 |
Why?
|
| Weight Loss | 2 | 2012 | 271 | 0.340 |
Why?
|
| Citalopram | 2 | 2012 | 19 | 0.320 |
Why?
|
| Resistance Training | 3 | 2018 | 102 | 0.300 |
Why?
|
| Nutrition Disorders | 1 | 2007 | 11 | 0.300 |
Why?
|
| Appetite Stimulants | 1 | 2007 | 5 | 0.300 |
Why?
|
| Urinary Retention | 1 | 2006 | 7 | 0.290 |
Why?
|
| Antipsychotic Agents | 2 | 2022 | 242 | 0.290 |
Why?
|
| Long-Term Care | 1 | 2007 | 59 | 0.290 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 2388 | 0.290 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 1698 | 0.280 |
Why?
|
| Simvastatin | 1 | 2006 | 35 | 0.280 |
Why?
|
| Quinolones | 1 | 2006 | 35 | 0.280 |
Why?
|
| Dietary Supplements | 3 | 2018 | 457 | 0.270 |
Why?
|
| Piperazines | 1 | 2006 | 115 | 0.270 |
Why?
|
| Exercise | 2 | 2020 | 552 | 0.270 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2023 | 25 | 0.260 |
Why?
|
| Antidepressive Agents | 2 | 2020 | 188 | 0.260 |
Why?
|
| Arkansas | 2 | 2021 | 2098 | 0.250 |
Why?
|
| Prospective Studies | 5 | 2020 | 2605 | 0.250 |
Why?
|
| Treatment Outcome | 8 | 2023 | 5610 | 0.240 |
Why?
|
| Diet | 1 | 2007 | 598 | 0.210 |
Why?
|
| Muscle, Skeletal | 3 | 2018 | 848 | 0.210 |
Why?
|
| Lithium | 1 | 2022 | 40 | 0.210 |
Why?
|
| Patient Acuity | 2 | 2022 | 16 | 0.210 |
Why?
|
| Energy Intake | 2 | 2012 | 196 | 0.200 |
Why?
|
| Time Factors | 4 | 2018 | 3203 | 0.200 |
Why?
|
| Incineration | 1 | 2021 | 6 | 0.200 |
Why?
|
| Risk Factors | 4 | 2022 | 3931 | 0.200 |
Why?
|
| Suicide, Attempted | 1 | 2022 | 73 | 0.190 |
Why?
|
| Hypesthesia | 1 | 2020 | 18 | 0.190 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 28 | 0.190 |
Why?
|
| Electronic Mail | 1 | 2020 | 19 | 0.190 |
Why?
|
| Medical Staff | 1 | 2020 | 6 | 0.190 |
Why?
|
| Memory Disorders | 1 | 2020 | 62 | 0.180 |
Why?
|
| Geriatrics | 1 | 2020 | 47 | 0.180 |
Why?
|
| Jogging | 1 | 2020 | 2 | 0.180 |
Why?
|
| Trazodone | 1 | 2020 | 6 | 0.180 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 159 | 0.180 |
Why?
|
| Affective Symptoms | 1 | 2020 | 22 | 0.180 |
Why?
|
| Bipolar Disorder | 1 | 2022 | 209 | 0.180 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 231 | 0.170 |
Why?
|
| Research Personnel | 1 | 2020 | 69 | 0.170 |
Why?
|
| Patient Safety | 1 | 2020 | 121 | 0.170 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 241 | 0.170 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 389 | 0.170 |
Why?
|
| Parkinson Disease | 1 | 2021 | 180 | 0.170 |
Why?
|
| Thigh | 1 | 2018 | 40 | 0.160 |
Why?
|
| Adult | 5 | 2023 | 14177 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2018 | 8 | 0.160 |
Why?
|
| Medication Therapy Management | 1 | 2018 | 24 | 0.150 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 119 | 0.150 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 327 | 0.150 |
Why?
|
| Geriatric Assessment | 4 | 2015 | 126 | 0.150 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 137 | 0.150 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 19 | 0.150 |
Why?
|
| Hospitalization | 2 | 2022 | 702 | 0.150 |
Why?
|
| Video Recording | 1 | 2017 | 90 | 0.140 |
Why?
|
| Rehabilitation Centers | 2 | 2012 | 37 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 133 | 0.140 |
Why?
|
| Risk Assessment | 1 | 2020 | 1361 | 0.130 |
Why?
|
| Immune System | 1 | 2015 | 49 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 484 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 103 | 0.120 |
Why?
|
| Clinical Protocols | 1 | 2015 | 121 | 0.120 |
Why?
|
| RNA, Messenger | 1 | 2018 | 1202 | 0.120 |
Why?
|
| Neuropsychological Tests | 1 | 2015 | 362 | 0.110 |
Why?
|
| Hospital Units | 1 | 2012 | 13 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 1218 | 0.110 |
Why?
|
| Physical Endurance | 1 | 2012 | 49 | 0.110 |
Why?
|
| Leg | 1 | 2012 | 130 | 0.110 |
Why?
|
| Edema | 1 | 2012 | 74 | 0.100 |
Why?
|
| Cholesterol | 1 | 2012 | 155 | 0.100 |
Why?
|
| Malnutrition | 1 | 2012 | 82 | 0.100 |
Why?
|
| Young Adult | 2 | 2022 | 4312 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2012 | 222 | 0.100 |
Why?
|
| Brain | 1 | 2020 | 1388 | 0.100 |
Why?
|
| Aging | 2 | 2018 | 784 | 0.100 |
Why?
|
| Weight Gain | 1 | 2012 | 243 | 0.100 |
Why?
|
| Asymptomatic Diseases | 1 | 2021 | 43 | 0.100 |
Why?
|
| Nutrition Assessment | 2 | 2012 | 80 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2012 | 635 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2022 | 513 | 0.090 |
Why?
|
| Dietary Proteins | 1 | 2012 | 230 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 429 | 0.090 |
Why?
|
| Adolescent | 2 | 2022 | 6892 | 0.090 |
Why?
|
| Inflammation | 1 | 2012 | 678 | 0.080 |
Why?
|
| Incidence | 1 | 2021 | 1082 | 0.080 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2006 | 7 | 0.070 |
Why?
|
| Syndrome | 2 | 2020 | 253 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 426 | 0.070 |
Why?
|
| Schizophrenia | 1 | 2006 | 268 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2020 | 6462 | 0.060 |
Why?
|
| Fructose | 1 | 2023 | 28 | 0.060 |
Why?
|
| Aftercare | 1 | 2023 | 82 | 0.050 |
Why?
|
| Antimanic Agents | 1 | 2022 | 14 | 0.050 |
Why?
|
| Acetylcholinesterase | 1 | 2021 | 21 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2022 | 96 | 0.050 |
Why?
|
| Geriatric Psychiatry | 1 | 2020 | 11 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2023 | 353 | 0.050 |
Why?
|
| Receptors, Dopamine | 1 | 2020 | 22 | 0.050 |
Why?
|
| Europe | 1 | 2020 | 103 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2020 | 48 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2020 | 75 | 0.040 |
Why?
|
| Gait | 1 | 2020 | 98 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 254 | 0.040 |
Why?
|
| Organ Size | 1 | 2018 | 236 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2018 | 48 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 91 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2018 | 88 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 249 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2018 | 208 | 0.040 |
Why?
|
| Comorbidity | 1 | 2018 | 666 | 0.030 |
Why?
|
| United States | 2 | 2018 | 5206 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2015 | 44 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 595 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2018 | 516 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2015 | 125 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1083 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 397 | 0.030 |
Why?
|
| Intermediate Care Facilities | 1 | 2012 | 6 | 0.030 |
Why?
|
| Prealbumin | 1 | 2012 | 24 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2012 | 62 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 121 | 0.030 |
Why?
|
| Fluoxetine | 1 | 2012 | 48 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 160 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2012 | 158 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2012 | 315 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 431 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 577 | 0.020 |
Why?
|
| Rural Population | 1 | 2015 | 595 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2012 | 489 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 309 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1543 | 0.020 |
Why?
|